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We have purified a 38 kDa protein from bovine brain which is cross-reactive with an affinity purified antibody against he 35 kDa phosphatidylino- 
sitol transfer protein from the same source. Controlled trypsinization of the 38 kDa protein yielded an immunoreactive protein of 35 kDa which 
displayed a 6-fold increase in phosphatidylinositol transfer activity and a IO-fold higher affinity for this phospholipid. The possibility that the 38 
kDa protein is a precursor of the phosphatidylinositol transfer protein is discussed. 
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1. INTRODUCTION 
Phosphatidylinositol transfer proteins (PI-TP) 
facilitate the transfer of phosphatidylinositol (PI) and, 
to a lesser extent, phosphatidylcholine (PC) between 
membranes in vitro [l-3]. The proteins are present in 
cytosolic fractions from mammalian, avian, reptile, 
amphibian and insect tissues, and have an apparent 
molecular mass ranging from 33 kDa to 35 kDa depen- 
ding on the species [4]. Cross-reactivity of antibodies 
raised against bovine brain PI-TP, with PI-TP from 
other sources indicates its conserved nature. However, 
it is noteworthy that PI-TP purified from yeast is not 
cross-reactive with this antibody [5]. Recently, it was 
demonstrated that deletion of the PI-TP gene is lethal 
for the yeast cell [6]. cDNA analysis has indicated that 
yeast is identical to the SEC14 protein which plays an 
essential role in vesicle-mediated protein secretion [7]. 
Binding of either PI or PC to PI-TP results in two 
forms of the protein (PI-TP I and II) with different 
isoelectric points (5.5 and 5.7, respectively). Moreover, 
the affinity of PI-TP for PI is 16 times higher than for 
PC [8]. Using pyrenylacyl-labeled PI and PC analogs 
with acyl chains of different length, it was shown that 
PI-TP has a preference for pyrenyl-octanoyl and - 
decanoyl chains [9]. Furthermore, it was shown that PI- 
TP has different binding sites for the l- and 2-acyl 
chains. 
Recently, it was reported that, in addition to the 35 kDa 
PI-TP, mature mammalian testis contain a PI-TP with 
a molecular mass of 41 kDa [lo]. This PI-TP is able to 
transfer PI and PC but its structural and catalytic rela- 
tionship with the 35 kDa PI-TP is unclear. The 
physiological role of mammalian PI-TP still remains to 
be determined. It has been suggested that PI-TP is in- 
volved in the control of PI levels in the membranes of 
cellular organelles and in the plasma membrane [1 I]. 
In the present paper we report the purification of a 38 
kDa protein from bovine brain which is cross-reactive 
with an affinity purified polyclonal antiserum against 
bovine brain PI-TP (35 kDa). Compared to PI-TP this 
cross-reactive protein has a very low ability to bind and 
transfer PI. However, upon mild trypsinization of the 
38 kDa protein a 35 kDa protein is produced, which 
shows a distinct increase in PI binding and PI transfer 
activity. These findings suggest hat the 38 kDa protein 
may be a precursor protein of PI-TP. Analysis of the 38 
kDa protein under various physiological conditions 
may provide information about a possible precur- 
sot-/PI-TP relationship and, thus, on the physiological 
role of PI-TP. 
2. MATERIALS AND METHODS 
2.1. Purification of PI- TP and the 38 kDa protein from bovine brain 
Purification of PI-TP and the related 38 kDa protein has been car- 
ried out following a procedure for the isolation of PI-TP from bovine 
brain, as described by van Paridon et al. [8]. The difference in 
molecular mass made it possible to discriminate between the cross- 
reactive 38 kDa protein and the 35 kDa PI-TP by SDS-PAGE im- 
munoblotting. During the purification the fractions were routinely 
tested for PI-transfer activity and immunoreactivity (ELISA and im- 
munoblotting, see below). 
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Centre for Biomembranes and Lipid Enzymology, Transitorium III, 
Padualaan 8, 3584 CH Utrecht, The Netherlands 
bovine brains was made in a buffer containing 20 mM Tris-HCl (pH 
7.4), 1 mM EDTA, 1 mM PMSF and 0.9% NaCI. Following cen- 
Published by Elsevier Science Publishers B. K (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 123 
Volume 276, number 1,2 FEBSLETTERS December 1990 
trifugation at 14 000 x g for 1 h, ammonium sulphate precipitation 
(70% saturation) of the supernatant was carried out overnight. After 
centrifugation the pellet was resuspended in a sodium phosphate buf- 
fer (5 mM Na-phosphate pH 7.2, 10 mM 2-mercaptoethanol) and ex- 
tensively dialysed against this phosphate buffer. The dialysate was ap- 
plied to a DEAE-cellulose Whatman (DE52) column (6 x 80 cm) and 
eluted with a linear gradient of O-300 mM NaCl in the sodium- 
phosphate buffer. The fractions which showed transfer activity and 
immunoreactivity were identical. These fractions were combined and 
applied to a Sephadex G-75 column (Pharmacia, 4 x 160 cm). The ac- 
tive fractions were combined, glycerol was added to a final concentra- 
tion of 10% (v/v) and the sample was applied to a hydroxyapatite col- 
umn (Biogel, HTP, Biorad; 2.2 x 31 cm) and eluted with a 5-200 mM 
potassium-phosphate gradient, pH 6.8, in 10% glycerol. The active 
fractions identified by the transfer assay and by immunoreactivity 
assays were purified further on a chromatofocusing column (PBB94, 
Polybuffer 74-HCl, Pharmacia; 30 ml). Ampholines present in the 
positive fractions were removed on a Sephadex G-75 column. Pro- 
teins were stored in 50% glycerol (v/v) at -20°C. 
2.2. Phospholipid transfer and binding assays 
Phosphatidylinositol transfer activity was measured by the fluores- 
cent lipid transfer assay as described by Somerharju et al. [ 121. Donor 
vesicles consisted of 2-pyrenyl-decanoyl-PI/egg PC/ trinitrophenol- 
phosphatidylethanolamine (30:60: 10 mol%). Acceptor vesicles con- 
sisted of PC and phosphatidic acid (95:5 mol%). 
Binding studies between protein and pyrene-labeled phospholipids 
were carried out as described [9]. Donor vesicles consisted of Z-py- 
renyl-decanoyl-PI/egg PCYtrinitrophenolphosphatidyl-ethanolamine 
(45:45:10 mol%). 
2.3. Antisera and enzyme-linked immunosorbent assay 
A polyclonal antiserum directed against purified bovine PI-TP was 
produced in rabbits according to standard procedures. IgG specific 
antibodies were isolated by DEAE-cellulose chromatography follow- 
ed by affinity chromatography with pure bovine brain 35 kDa PI-TP 
coupled to a carrier. An enzyme-linked immunosorbent assay 
(ELISA) was used to determine the presence of immunoreactive pro- 
teins. 
2.4. Electrophoresis and immunoblotting 
Proteins were separated by SDS-polyacrylamide gel elec- 
trophoresis, using a 11% acrylamide running gel. Proteins were 
visualized by Coomassie blue staining or silver staining. For im- 
munological detection the proteins were transferred electrophoretical- 
ly to nitrocellulose membranes (Schleicher and Schuell) and 
developed immunochemically. 
2.5. Trypsinization 
Tryptic &gestion (EC 3.4.21.4, Boehringer) was carried out in a 
sucrose buffer (0.25 M sucrose, 1 mM EDTA and 5 mM Tris-HCl, pH 
7.4) for 90 min at 37°C. The ratio protein/trypsin was 2.5 (w/w). 
Digestion was terminated by chilling on ice. 
3. RESULTS 
Fractionation of cytosolic proteins from bovine brain 
on DEAE-cellulose and Sephadex G-75 yielded one im- 
munoreactive peak which coincided with PI-transfer ac- 
tivity. Subsequent fractionation on a hydroxyapatite 
column gave two immunoreactive peaks of which one 
eluted at 60 mM sodium phosphate (fractions 36-55, 
peak I) and another at 100 mM sodium phosphate (frac- 
tions 56-80, peak II, see Fig. 1). Determination of the 
PI transfer activity revealed that peak II contained two 
active peaks whereas peak I was virtually inactive. 
Chromatofocusing of peak II again yielded two frac- 
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Fig. 1. Separation of PI-TP and the 38 kDa protein by 
chromatography on a hydroxyapatite column. For experimental 
details see section 2.1. (- - -) 5-200 mM potassium-phosphate gra- 
dient . 
tions with transfer activity. This separation can be 
ascribed to the phospholipid (PI or PC) bound to PI-TP 
(see introduction). Chromatofusing showed that peak I 
also consisted of two immunoreactive fractions. Their 
isoelectric points differed 0.2 units. This is the same as 
observed for PI-TP I and II. Moreover, the inactive 
proteins had an isoelectric point of 0.2-0.4 pH units 
lower than observed for PI-TP. Immunoblot analysis 
of the 4 fractions obtained from chromatofocusing 
revealed that peak II consisted mainly of PI-TP (i% 35 
kDa), whereas peak I consisted of a cross-reactive pro- 
tein with a molecular mass of 38 kDa. 
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Fig. 2. Proteolytic activation of the 38 kDa protein. PI-transfer ac- 
tivity before and after controlled trypsinization (90 min, 37°C) of the 
38 kDa protein, curve 1 and curve 2, respectively. Transfer activity of 
a comparable amount of PI-TP is shown in curve 3. 




Fig. 3. Time-dependent proteolysis of the 38 kDa protein as deter- 
mined by immunoblot analysis. Lane 1: 0.15 mg 38 kDa protein. Lane 
2-5: 0.15 mg 38 kDa protein after 10, 30, 60, and 120 min trypsin 
treatment, respectively. Lane 6: 0.15 mg 38 kDa protein incubated 
under identical conditions for 120 min without trypsin. 
As shown in Fig. 2, PI transfer activity of the 38 kDa 
protein (curve 1) is about l-2% of the activity of PI-TP 
(curve 3). However, a (i-fold increase of PI-transfer ac- 
tivity was observed when the 38 kDa protein was sub- 
mitted to controlled trypsin degradation (curve 2). It is 
shown in Fig. 3 that due to trypsin degradation the 38 
kDa protein is converted into a 35 kDa protein which is 
cross-reactive with the antibody against PI-TP. 
The affinity of PI-TP, of the 38 kDa protein and its 35 
kDa degradation product for PI was compared in 
binding experiments. As can be seen from Fig. 4 (panel 
A and B) the affinity of the 38 kDa protein for PI is 
about 2% of that observed for PI-TP. After controlled 
trypsinization of the 38 kDa protein the affinity for PI 
was lo-fold increased (panel C). 
4. DISCUSSION 
In the present study we show that bovine brain 
cytosol contains a 38 kDa protein which is related to PI- 
TP. This 38 kDa protein is cross-reactive with the 
affinity-purified polyclonal antibodies against bovine 
brain PI-TP. Its close relationship with PI-TP was fur- 
ther demonstrated by its cross-reactivity with a 
polyclonal antiserum against synthetic peptides design- 
ed on the basis of predicted B and T cell epitopes of rat 
brain PI-TP (I.S.C. de Wit, personal communication). 
Both the 38 kDa protein and PI-TP occur in two forms 
which can be distinquished on the basis of their dif- 
ferent isoelectric points. The two forms of PI-TP are 
due to the fact that binding of their PI or PC causes a 
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Fig. 4. Binding of pyrene-labeled PI to PI-TP (A), the 38 kDa protein 
(B) and its 35 kDa proteolytic product (C). Comparible amounts of 
protein were added to quenched donor vesicles containing pyrene- 
labeled PI (see arrow) and the fluorescence intensity was recorded as 
a function of time (emission at 377 nm.). 
difference of one negative charge [8]. At this point we 
have no explanation for the occurrence of two forms of 
the 38 kDa protein. 
Evidence that the 38 kDa protein is an inactive 
precursor of PI-TP, followed from trypsin degradation 
experiments. Controlled trypsinization of the 38 kDa 
protein results in an immunoreactive 35 kDa protein 
which has a 6-fold increased PI-transfer activity. It 
follows from Fig. 2 that the newly formed 35 kDa pro- 
tein is not as active in PI transfer as PI-TP. This could 
be due to the fact that the cleavage site for trypsin is dif- 
ferent from that for the putative endogenous cellular 
protease. Moreover, incubation of PI-TP with trypsin 
under comparable conditions leads to a 2-fold decrease 
in PI-transfer activity (data not shown, [I]). 
Recently, it was reported that the cytosolic fraction 
of mature testis contains an additional PI-TP species of 
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41 kDa [lo]. This immuno cross-reactive PI-TP is ex- 
clusive for testis and has both PI and PC transfer activi- 
ty comparible to that of the 35 kDa PI-TP. It remains 
to be established in what way the 41 kDa PI-TP, the 38 
kDa protein and PI-TP are related. 
A cDNA encoding for rat brain PI-TP has been se- 
quenced and the deduced amino acid sequence defines 
a protein with a molecular mass of 35 kDa [4]. 
However, DNA and mRNA hybridization experiments 
indicate that related genes and/or introns are present. It 
is therefore expected that one of these related genes en- 
codes for the 38 kDa protein. 
It is generally accepted that the ability of PI-TP to 
bind and transfer PI/PC is directly connected with its 
physiological role [13]. The conversion of an inactive 
precursor PI-TP into an active form is an efficient way 
to increase the pool of active PI-TP on short notice.If 
the 38 kDa protein described here is indeed a precursor 
of the 35 kDa PI-TP, information about the cellular 
conditions affecting the relative presence of the precur- 
sor protein and the active PI-TP, may increase our 
knowledge on the physiological role of PI-TP. 
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